According to a May 16th article from PharmTech, 36% of pharmaceutical manufacturers and contract packagers aren’t properly set-up to meet global requirements for serialization. The information comes from a survey conducted by serialization provider SEA Vision and life sciences technology company Zenith Technologies. Here are some more stats from the survey:
- 51% of respondents who are not prepared to meet the regulations blame lack of internal resources
- 15% of respondents who aren’t prepared believe it’s too early to begin preparations
- 56% of respondents have begun the serialization journey with only compliance in mind
- 44% of respondents say they plan to utilize serialization to achieve broader business benefits
“While serialization presents a number of challenges, it also creates an opportunity to review business processes and improve productivity. Those companies that embrace the changes and make preparing for the DSCSA and the FMD a priority, have a real opportunity to differentiate their offering, and it is our goal to support this process,”says Carlos Machado, serialization director at SEA Vision US.
![“Another key [UDI] benefit, because we're calling that product by the same name across the healthcare supply chain… rich and robust data that we can access around supply consumption and utilization rates. One of the buzz terms we've heard during the COVID-19 crisis was what's my burn rate? How fast am I going through gowns, masks, gloves?” – Mike Schiller, Senior Director at AHRMM](https://img.healthcarepackaging.com/files/base/pmmi/all/image/2020/08/UDI.5f4d326e41d53.png?auto=format&fit=crop&h=146&w=340)
